このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Biolog Device マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Hwang Hoon

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	3.2yrs
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

更新なし

Recent updates

CEO（最高経営責任者

Hwang Hoon

3.2yrs

在職期間

Hwang Hoon is Chief Executive Officer at Biolog Device Co., Ltd. since April 2021.

Biolog Device マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

Recent updates

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

Full year 2023 earnings released: ₩130 loss per share (vs ₩45.67 profit in FY 2022)

New minor risk - Shareholder dilution

Biolog Device Co., Ltd. announced that it expects to receive KRW 14.999999047 billion in funding

New minor risk - Share price stability

Full year 2022 earnings released: EPS: ₩67.97 (vs ₩190 loss in FY 2021)

Biolog Device Co., Ltd. announced that it expects to receive KRW 10 billion in funding

Biolog Device Co., Ltd. announced that it has received KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Investor sentiment deteriorated over the past week

Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710).

Unibada, Han International, Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710) for KRW 15.5 billion.

Biolog Device Co., Ltd. announced that it has received KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

New 90-day high: ₩1,800

Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

New 90-day low - ₩1,480

CEO（最高経営責任者

在職期間

Biolog Device マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Recent updates

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

Full year 2023 earnings released: ₩130 loss per share (vs ₩45.67 profit in FY 2022)

New minor risk - Shareholder dilution

Biolog Device Co., Ltd. announced that it expects to receive KRW 14.999999047 billion in funding

New minor risk - Share price stability

Full year 2022 earnings released: EPS: ₩67.97 (vs ₩190 loss in FY 2021)

Biolog Device Co., Ltd. announced that it expects to receive KRW 10 billion in funding

Biolog Device Co., Ltd. announced that it has received KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 6.5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Investor sentiment deteriorated over the past week

Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710).

Unibada, Han International, Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd (KOSDAQ:A078650) from Biolog Device Co., Ltd. (KOSDAQ:A208710) for KRW 15.5 billion.

Biolog Device Co., Ltd. announced that it has received KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

Biolog Device Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm

We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

New 90-day high: ₩1,800

Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

New 90-day low - ₩1,480

CEO（最高経営責任者

在職期間

マネジメント基準チェック /04